Myron Z. Holubiak, Director at BioScrip, Inc. (BIOS), sold 31,200 shares at $16.34 ($510K) on 2013-07-19, disclosed to the SEC on 2013-07-23.
Scheduled sale ($510k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTXR | BUY | 2018-08-15 | $2.0M | — | Filing → |
| CTXR | BUY | 2018-03-29 | $9K | — | Filing → |
| BIOS | SELL | 2014-06-18 | $40K | — | Filing → |